Vibeden 1 mg/ml injektionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

vibeden 1 mg/ml injektionsvæske, opløsning

sandoz a/s - hydroxocobalaminchloride - injektionsvæske, opløsning - 1 mg/ml

Nordimet Den Europæiske Union - dansk - EMA (European Medicines Agency)

nordimet

nordic group b.v. - methotrexat - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastiske midler - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.

Ceftazidim "MIP" 1 g pulver til injektions-/infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ceftazidim "mip" 1 g pulver til injektions-/infusionsvæske, opløsning

mip pharma gmbh - ceftazidimpentahydrat - pulver til injektions-/infusionsvæske, opløsning - 1 g

Ceftazidim "MIP" 2 g pulver til injektions-/infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ceftazidim "mip" 2 g pulver til injektions-/infusionsvæske, opløsning

mip pharma gmbh - ceftazidimpentahydrat - pulver til injektions-/infusionsvæske, opløsning - 2 g